Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL503732 | 0.85 | LMNA (0.35) | LMNACYP2C9 | |
| SCHEMBL8781384 | 0.85 | LMNA (0.35) | LMNACYP2C9 | |
| SCHEMBL19257963 | 0.84 | POLB (0.31) | POLB | |
| SCHEMBL7349981 | 0.81 | LMNA (0.32) | LMNACYP2C9POLB | |
| SCHEMBL10355569 | 0.81 | LMNA (0.36) | LMNACYP2C9 | |
| SCHEMBL19257640 | 0.80 | POLB (0.32) | POLB | |
| SCHEMBL7265277 | 0.75 | LMNA (0.39) | LMNA | |
| SCHEMBL5784031 | 0.70 | — | — | |
| SCHEMBL1380065 | 0.70 | — | — | |
| SCHEMBL7292447 | 0.69 | LMNA (0.40) | LMNACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020151501-A1 | Compounds having growth hormone releasing activity | BOWERS CYRIL Y (US) | 2002-10-17 | — | — | US | claimed |
| EP-1159292-A2 | COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY | Administrators of The Tulane Educational Fund (US) | 2001-12-05 | — | — | EP | claimed |
| WO-2000009537-A2 | COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY | ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2000-02-24 | — | — | WO | claimed |
| CN-112603926-A | Atropine inosine eye drops for treating myopia and preparation method thereof | 河南合智医药科技有限公司 | 2021-04-06 | — | — | CN | disclosed |
| CN-111039852-A | N-ethylpyridine methylamine hydrochloride crystal, preparation process and application thereof in preparation of tropicamide | 卡博金艾美斯医药(上海)有限公司 | 2020-04-21 | — | — | CN | disclosed |
| CN-110950795-A | N-ethylpyridine methylamine methanesulfonate crystal, preparation process and application thereof in preparation of tropicamide | 卡博金艾美斯医药(上海)有限公司 | 2020-04-03 | — | — | CN | disclosed |
| CN-110872251-A | N-ethylpyridine methylamine trifluoroacetate and crystal, preparation process and application thereof | 卡博金艾美斯医药(上海)有限公司 | 2020-03-10 | — | — | CN | disclosed |
| CN-103159672-A | Preparation method of tropine amide | HUNAN IVEN BIO TECHNOLOGY CO LTD | 2013-06-19 | — | — | CN | disclosed |
| CN-103159672-A | Preparation method of tropine amide | HUNAN IVEN BIO TECHNOLOGY CO LTD | 2013-06-19 | — | — | CN | disclosed |
| US-7250399-B2 | Compounds having growth hormone releasing activity | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2007-07-31 | — | — | US | disclosed |
| US-20020161013-A1 | Method of local anesthesia and analgesia | WEX MEDICAL INTRUMENTATION CO., LTD. (HK) | 2002-10-31 | — | — | US | disclosed |
| US-6468974-B1 | OLIGOPEPTIDES THAT PROVIDE DESIRABLE IN VITRO AND IN VIVO GROWTH HORMONE RELEASING ACTIVITY AND HAVE AT LEAST ONE OTHER DESIRABLE BIOLOGICAL ACTIVITY SUCH AS INCREASED RETENTION TIME | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND | 2002-10-22 | — | — | US | disclosed |
| US-20020151501-A1 | Compounds having growth hormone releasing activity | BOWERS CYRIL Y (US) | 2002-10-17 | — | — | US | disclosed |
| EP-1159292-A2 | COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY | Administrators of The Tulane Educational Fund (US) | 2001-12-05 | — | — | EP | disclosed |
| WO-2000009537-A2 | COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY | ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2000-02-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020151501-A1 | Compounds having growth hormone releasing activity | GHSR, GHRHR, NPY1R | LMNA 4062/4885CYP2C9 4153/4885POLB 2047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.